Document Detail


Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate.
MedLine Citation:
PMID:  19832931     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Hyperandrogenism produces change in quality of life of women.
AIM: To prespectively determine the changes of the sexual behaviour of hyperandrogenic women using an oral contraceptive containing 30 microg ethinylestradiol and 2 mg chlormadinone acetate (EE/CMA).
METHODS: Seventy-two volunteer women (age range, 18-32 years), with moderate to severe hirsutim and acne were treated with EE/CMA for 9 cycles.
MAIN OUTCOMES MEASURE(S): To assess hirsutism, the Ferriman-Gallwey (F-G) scoring system was used. Serum FSH, LH, estradiol, total and free testosterone, DHEAS, androstenedione, and SHBG levels were measured at baseline and at the 9th cycle of pill intake. The Short Personal Experience Questionnaire (SPEQ), the Short Form-36 (SF-36), and a visual analog scales questionnaires were used to assess the QoL, at baseline and after 3, 6 and 9 cycles of pill use.
RESULT(S): A reduction of 65% and 81% in the total mean F-G score was observed after the 6th cycle and the 9th cycle, respectively. The serum Androstenedione, and total and free testosterone levels decreased, and SHBG levels increased after the 9th cycle (p < 0.05). The SF-36 score was higher after 6 (p < 0.05) 9 cycles (p < 0.001) with respect to baseline. Frequency of sexual intercourse and of orgasm by intercourse increased, and the frequency of masturbation decreased during the 6th (p < 0.05) and the 9th cycle (p < 0.001).
CONCLUSION(S): The EE/CMA pill has anti-androgenic properties reducing the anti-aesthetic effect of hyperandrogenism and improving female sexual and social self-esteem.
Authors:
Salvatore Caruso; Salvatore Rugolo; Carmela Agnello; Mattea Romano; Antonio Cianci
Publication Detail:
Type:  Journal Article     Date:  2009-10-14
Journal Detail:
Title:  The journal of sexual medicine     Volume:  6     ISSN:  1743-6109     ISO Abbreviation:  J Sex Med     Publication Date:  2009 Dec 
Date Detail:
Created Date:  2010-01-22     Completed Date:  2010-04-15     Revised Date:  2011-08-25    
Medline Journal Info:
Nlm Unique ID:  101230693     Medline TA:  J Sex Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3376-84     Citation Subset:  IM    
Affiliation:
Research Group for Sexology, Department of Microbiological Science and Gynaecological Science, University of Catania, Catania, Italy. scaruso@unict.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acne Vulgaris / diagnosis,  epidemiology
Adolescent
Androgen Antagonists / therapeutic use
Chlormadinone Acetate / therapeutic use*
Coitus
Contraceptives, Oral, Synthetic / therapeutic use*
Female
Hirsutism / diagnosis,  epidemiology
Humans
Hyperandrogenism / drug therapy*,  epidemiology*
Polycystic Ovary Syndrome / epidemiology
Prospective Studies
Quality of Life / psychology*
Questionnaires
Self Concept
Severity of Illness Index
Sexual Behavior / psychology*
Time Factors
Young Adult
Chemical
Reg. No./Substance:
0/Androgen Antagonists; 0/Contraceptives, Oral, Synthetic; 302-22-7/Chlormadinone Acetate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Myiasis after study trip to French Guiana.
Next Document:  Validation of a Women's Sexual Interest Diagnostic Interview-Short Form (WSID-SF) and a Daily Log of...